Dubuque Bank & Trust’s Avanos Medical AVNS Stock Holding History

Dubuque Bank & Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-150	Closed	-$6K	–	198
2019 Q1	$6K	Hold	150	–	–	﹤0.01%	540
2018 Q4	$7K	Buy	+150	New	+$7.86K	﹤0.01%	464
2018 Q3	–	Sell	-150	Closed	-$9K	–	632
2018 Q2	$9K	Sell	150 -12	-7%	-$634	﹤0.01%	467
2018 Q1	$8K	Buy	162 +1	+0.6%	+$47	﹤0.01%	519
2017 Q4	$8K	Buy	161 +11	+7%	+$506	﹤0.01%	519
2017 Q3	$7K	Hold	150	–	–	﹤0.01%	514
2017 Q2	$6K	Hold	150	–	–	﹤0.01%	499
2017 Q1	$6K	Hold	150	–	–	﹤0.01%	524
2016 Q4	$6K	Hold	150	–	–	﹤0.01%	463
2016 Q3	$5K	Hold	150	–	–	﹤0.01%	452
2016 Q2	$5K	Hold	150	–	–	﹤0.01%	482
2016 Q1	$4K	Hold	150	–	–	﹤0.01%	545
2015 Q4	$5K	Hold	150	–	–	﹤0.01%	614
2015 Q3	$4K	Sell	150 -9	-6%	-$314	﹤0.01%	511
2015 Q2	$6K	Buy	159 +141	+783%	+$6.33K	﹤0.01%	522
2015 Q1	$1K	Hold	18	–	–	﹤0.01%	590
2014 Q4	$1K	Buy	+18	New	+$707	﹤0.01%	547

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dubuque Bank & Trust's AVNS Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 150 shares — an estimated $6K sold.

Dubuque Bank & Trust first reported a position in AVNS in Q4 2014 and held it in 17 quarters. The position peaked at $9K in Q2 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Dubuque Bank & Trust reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Dubuque Bank & Trust sold 150 Avanos Medical shares in Q2 2019, an estimated $6K.
Dubuque Bank & Trust first reported a position in Avanos Medical in Q4 2014 and held it in 17 quarters.
Dubuque Bank & Trust's Avanos Medical position peaked at $9K in Q2 2018.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.